Literature DB >> 3174627

Modeling of the bryostatins to the phorbol ester pharmacophore on protein kinase C.

P A Wender1, C M Cribbs, K F Koehler, N A Sharkey, C L Herald, Y Kamano, G R Pettit, P M Blumberg.   

Abstract

The bryostatins are macrocyclic lactones that represent an additional structural class of potent activators of protein kinase C. These marine animal biosynthetic products are of unusual interest because they induce only a subset of the biological responses induced by the phorbol esters. We have now determined the binding affinities of naturally occurring and semisynthetic bryostatins for protein kinase C by competition analysis with [26-3H]bryostatin 4 as the radioactive ligand. Esterification of the hydroxyl group at C26 caused dramatic loss of activity as did inversion of the asymmetric center at this position. In contrast, neither of the ester groups at C7 and C20 had a major influence on activity. Computer modeling of the phorbol esters, related diterpenes, and indole alkaloids suggested that the C20, C9, and C4 oxygens of phorbol represented critical elements of the phorbol ester pharmacophore. The C26 oxygen of the bryostatins, together with the C1 and C19 oxygens, gave an excellent spatial correlation with this model, with a root-mean-square deviation of 0.16 A (compared to 0.10-0.35 A among phorbol-related diterpenes). The extension of the phorbol ester pharmacophore model to the bryostatins and its agreement with the structure-activity relations for the bryostatin class of compounds provide additional support for the validity of the model.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3174627      PMCID: PMC282151          DOI: 10.1073/pnas.85.19.7197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Analysis of the phorbol ester pharmacophore on protein kinase C as a guide to the rational design of new classes of analogs.

Authors:  P A Wender; K F Koehler; N A Sharkey; M L Dell'Aquila; P M Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 2.  The phorbol ester receptor: a phospholipid-regulated protein kinase.

Authors:  C L Ashendel
Journal:  Biochim Biophys Acta       Date:  1985-09-09

3.  Purification of stable protein kinase C from mouse brain cytosol by specific ligand elution using fast protein liquid chromatography.

Authors:  A Y Jeng; N A Sharkey; P M Blumberg
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

Review 4.  The role of protein kinase C in cell surface signal transduction and tumour promotion.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Estimation of tumor promoting activity and structure-function relationships of aplysiatoxins.

Authors:  M Suganuma; H Fujiki; T Tahira; C Cheuk; R E Moore; T Sugimura
Journal:  Carcinogenesis       Date:  1984-03       Impact factor: 4.944

7.  Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters.

Authors:  J B Smith; L Smith; G R Pettit
Journal:  Biochem Biophys Res Commun       Date:  1985-11-15       Impact factor: 3.575

8.  Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells.

Authors:  M L Dell'Aquila; C L Herald; Y Kamano; G R Pettit; P M Blumberg
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor.

Authors:  R L Berkow; A S Kraft
Journal:  Biochem Biophys Res Commun       Date:  1985-09-30       Impact factor: 3.575

10.  Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60.

Authors:  A S Kraft; J B Smith; R L Berkow
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  53 in total

1.  Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.

Authors:  Paul A Wender; Brian A Loy; Adam J Schrier
Journal:  Isr J Chem       Date:  2011-03-24       Impact factor: 3.333

Review 2.  Quantitative structure-activity relationships (QSAR) and molecular modelling in cancer research.

Authors:  H Kubinyi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

3.  Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.

Authors:  Lillian Seu; Steffanie Sabbaj; Alexandra Duverger; Frederic Wagner; Joshua C Anderson; Elizabeth Davies; Frank Wolschendorf; Christopher D Willey; Michael S Saag; Paul Goepfert; Olaf Kutsch
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

Review 4.  Drug development from marine natural products.

Authors:  Tadeusz F Molinski; Doralyn S Dalisay; Sarah L Lievens; Jonel P Saludes
Journal:  Nat Rev Drug Discov       Date:  2008-12-19       Impact factor: 84.694

5.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

6.  Efficient synthetic access to a new family of highly potent bryostatin analogues via a Prins-driven macrocyclization strategy.

Authors:  Paul A Wender; Brian A Dechristopher; Adam J Schrier
Journal:  J Am Chem Soc       Date:  2008-05-02       Impact factor: 15.419

7.  Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.

Authors:  Paul A Wender; Jeremy L Baryza; Stacey E Brenner; Brian A DeChristopher; Brian A Loy; Adam J Schrier; Vishal A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

Review 8.  Conformation-activity relationships of polyketide natural products.

Authors:  Erik M Larsen; Matthew R Wilson; Richard E Taylor
Journal:  Nat Prod Rep       Date:  2015-08       Impact factor: 13.423

9.  Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.

Authors:  Rana Abdelnabi; Daryl Staveness; Katherine E Near; Paul A Wender; Leen Delang; Johan Neyts; Pieter Leyssen
Journal:  Biochem Pharmacol       Date:  2016-09-21       Impact factor: 5.858

10.  Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.

Authors:  K G Steube; D Grunicke; H G Drexler
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.